These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26077877)

  • 1. GLOBAL PRICING POLICIES AND COST-EFFECTIVENESS OF TRASTUZUMAB IN LATIN AMERICA.
    Giffin RB
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):1. PubMed ID: 26077877
    [No Abstract]   [Full Text] [Related]  

  • 2. IMPLICATIONS OF GLOBAL PRICING POLICIES ON ACCESS TO INNOVATIVE DRUGS: THE CASE OF TRASTUZUMAB IN SEVEN LATIN AMERICAN COUNTRIES.
    Pichon-Riviere A; Garay OU; Augustovski F; Vallejos C; Huayanay L; Bueno Mdel P; Rodriguez A; de Andrade CJ; Buendía JA; Drummond M
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):2-11. PubMed ID: 25989703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value-Based Pricing in Latin America: How Far Away Are We?
    Mejía A; Gilardino R; Kristensen FB; Garrison LP;
    Value Health Reg Issues; 2018 Dec; 17():219-223. PubMed ID: 30528780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Institutionalizing health technology assessment for priority setting and health policy in Latin America: from regional endeavors to national experiences.
    Augustovski F; Alcaraz A; Caporale J; García Martí S; Pichon Riviere A
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):9-12. PubMed ID: 25420744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: the trastuzumab case.
    Ades F; Senterre C; Zardavas D; de Azambuja E; Popescu R; Parent F; Piccart M
    Eur J Cancer; 2014 Dec; 50(18):3089-97. PubMed ID: 25446375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving access to high-cost cancer drugs in Latin America: Much to be done.
    Ruiz R; Strasser-Weippl K; Touya D; Herrero Vincent C; Hernandez-Blanquisett A; St Louis J; Bukowski A; Goss PE
    Cancer; 2017 Apr; 123(8):1313-1323. PubMed ID: 28182258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America.
    Glassman A; Cañón O; Silverman R
    Value Health; 2016 Dec; 19(8):913-920. PubMed ID: 27987640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thinking about long-term care policies for Latin America.
    Matus-López M
    Salud Colect; 2015 Dec; 11(4):485-96. PubMed ID: 26676592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental health policy developments in Latin America.
    Alarcón RD; Aguilar-Gaxiola SA
    Bull World Health Organ; 2000; 78(4):483-90. PubMed ID: 10885167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of intellectual disability in Latin American countries: epidemiology, policy, and services for children and adults.
    Mercadante MT; Evans-Lacko S; Paula CS
    Curr Opin Psychiatry; 2009 Sep; 22(5):469-74. PubMed ID: 19561502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving Beyond GDP: Cost Effectiveness of Cochlear Implantation and Deaf Education in Latin America.
    Emmett SD; Tucci DL; Bento RF; Garcia JM; Juman S; Chiossone-Kerdel JA; Liu TJ; de Muñoz PC; Ullauri A; Letort JJ; Mansilla T; Urquijo DP; Aparicio ML; Gong W; Francis HW; Saunders JE
    Otol Neurotol; 2016 Sep; 37(8):1040-8. PubMed ID: 27518131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes towards drug policies in Latin America: Results from a Latin-American Survey.
    Mendiburo-Seguel A; Vargas S; Oyanedel JC; Torres F; Vergara E; Hough M
    Int J Drug Policy; 2017 Mar; 41():8-13. PubMed ID: 27988428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries.
    Colantonio L; Gómez JA; Demarteau N; Standaert B; Pichón-Rivière A; Augustovski F
    Vaccine; 2009 Sep; 27(40):5519-29. PubMed ID: 19616499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nursing in the 21st century in Latin America: Part III--Policies.
    de Monterrossa E; Lange I; Chompré RR
    Int Nurs Rev; 1990; 37(4):303-6. PubMed ID: 2228465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is equity of access to health care achievable in Latin America?
    Araújo GT; Caporale JE; Stefani S; Pinto D; Caso A
    Value Health; 2011; 14(5 Suppl 1):S8-12. PubMed ID: 21839905
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementing pharmacoeconomic guidelines in Latin America: lessons learned.
    Augustovski F; Melendez G; Lemgruber A; Drummond M
    Value Health; 2011; 14(5 Suppl 1):S3-7. PubMed ID: 21839895
    [No Abstract]   [Full Text] [Related]  

  • 18. Health policies and systems in Latin America: regional identity and national singularities.
    Machado CV; Lima LD
    Cad Saude Publica; 2017 Jul; 33Suppl 2(Suppl 2):e00068617. PubMed ID: 28767811
    [No Abstract]   [Full Text] [Related]  

  • 19. [The foundation of international migration policies in Latin America].
    Marmora L
    Estud Migr Latinoam; 1988 Dec; 3(10):375-96. PubMed ID: 12282245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A basis for the formulation of policies on health science and technology in Latin America.
    Pellegrini Filho A
    Bull Pan Am Health Organ; 1994 Dec; 28(4):331-43. PubMed ID: 7858647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.